Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Bioequivalence Study Comparing Abemaciclib Capsule and Tablet Formulations and Effect of Food on Abemaciclib Tablet Pharmacokinetics in Healthy Subjects

NCT02672423 is registered in ClinicalTrials.gov with Eli Lilly and Company as lead sponsor.

NCT NCT02672423
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02672423 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Bioequivalence Study Comparing Abemaciclib Capsule and Tablet Formulations and Effect of Food on Abemaciclib Tablet Pharmacokinetics in Healthy Subjects
Lead sponsor
Eli Lilly and Company
Phase
Phase 1
Overall status
Completed
Start date
February 29, 2016
Completion date
October 31, 2016
Enrollment
127 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

healthy